NCT06609876
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
- Locations
-
- Chinese PLA General hospital Beijing, None Selected, China
Clinical trial condition
Donafenib
Explore clinical trials studying Donafenib. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Donafenib trial results
NCT04962958
- Conditions
- Adenocarcinoma, Antimetabolites, Antineoplastic Agents, +13 more
- Locations
-
- Lei Zhang Guangzhou, Guangdong, China
Completed
A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC
NCT05262959
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality, China